SCHEMBL13627282

SCHEMBL13627282

Nc1cc2c(Oc3ccc4[nH]ccc4c3)ccnc2cc1OC[C@H](O)CN1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR2 P21802 2/20 0.50
LTA4H P09960 1/20 0.42
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ATM Q13315 1/20 0.40
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 1/20 0.39
HTR1A P08908 3/20 0.39
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
MET P08581 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ACE2 Q9BYF1 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1896836 0.89 FGFR2 (0.49) FGFR2LTA4HADRB2ADRB1ADRB3
SCHEMBL1896841 0.89 FGFR2 (0.49) FGFR2LTA4HADRB2ADRB1ADRB3
SCHEMBL13627281 0.84 LTA4H (0.52) FGFR2LTA4HMET
SCHEMBL4379517 0.77 FGFR2 (0.49) FGFR2MET
SCHEMBL4379503 0.77 FGFR2 (0.49) FGFR2MET
SCHEMBL4384209 0.77 FGFR2 (0.49) FGFR2MET
SCHEMBL14540555 0.77 PDGFRB (0.45) MET
SCHEMBL12502130 0.77 FGFR2 (0.46) FGFR2ALDH1A1HPGDTSHRMET
SCHEMBL4381025 0.76 FGFR2 (0.50) FGFR2METMEN1KMT2A
SCHEMBL4381034 0.76 FGFR2 (0.50) FGFR2METMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612092-B2 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed